you can do pets too right? the amount of pets dying etc from lyme disease is crazy

Hi John, thanks for your inquiry. We will not be treating pets through Ravel, at least not to start. Please let us know if you have any other questions, thank you.

Do you have the app launched? Do you partner with app development partners?

Hi Majed, our digital health platform and services have launched and are up and running! We don't have a mobile app yet but we do have a mobile-optimized site, thanks: https://ravel.health/

That's good to hear. So you only have a web app as of yet? Regarding mobile development would that come later once you have a mobile development team?

Correct, website/web app. We already have a dev team in place, but we'll be building out our current platform and bringing in AI prior to considering a mobile app. Thanks!

Thank you for answering. Who gave valuation of 9M? Also, what/when is exit plan?

Hi Yaacov, thanks for reaching out, we're at $10K MRR. Please let us know if you have any other questions.

Have you considered offering alternative options such as 3-month or 6-month packages, or a maintenance plan for long-term customers? I'm curious on the intent of subscription based model-

Thanks for your question! We haven't looked at 3-month or 6-month packages, but we do have a Maintenance Subscription ($65/month), which is available after the initial visit and 2 subsequent visits. The reason for the subscription model is that we're big believers in continuity of care and monthly touchpoints. These are extremely challenging conditions and we want patients to be able to have consistent access to their providers throughout their health journey.

Ravel Health

Virtual Care for Lyme, Long COVID & Complex Chronic Illness

ravel.health

Denver, CO

Female Founder Healthcare B2C Subscription Health & Fitness

What Investors Say

President of Peninsula Capital Managemen

LEAD INVESTOR

Invested $200,000 this round + $50,000 previously

At Peninsula Capital Management, we invest in companies that disrupt industries and create lasting impact. Ravel Health is exactly that — a transformative force in healthcare for Lyme and Long COVID.
From our first conversation with the founders, we saw a unique combination of visionary leadership, data-driven innovation, and a relentless commitment to improving patient outcomes. Ravel is addressing critical inefficiencies in healthcare with a personalized approach that is poised to change the industry.
But what truly sets Ravel apart is its team — passionate, experienced, and fully dedicated to revolutionizing the space. We are confident that Ravel is not just a smart investment, but a company that will redefine the future of health. We’re proud to support their journey and excited for what’s to come.

What People Say

Ravel Health

Quick facts

Team profiles

Featured investor profiles

$340,230

What Investors Say